Deventer Ziekenhuis

At Deventer Ziekenhuis, clinical research in cardiovascular diseases focuses on major heart and blood vessel conditions such as acute coronary syndrome, acute myocardial infarction, atrial fibrillation, atherosclerosis, and heart failure. These studies are designed to test new ways to prevent serious events, improve symptom control, and reduce the risk of future complications.

• Preventing major cardiovascular events in high-risk patients
• Improving treatment options for atrial fibrillation and recurrent heart attack risk
• Evaluating therapies for heart failure with inflammation or pulmonary hypertension
• Studying lipid-related risks such as elevated lipoprotein(a) and atherosclerotic disease

Overall, this area reflects a strong interest in better prevention, safer treatment strategies, and more effective long-term cardiovascular care.

Research in neoplasms at this hospital covers several cancers, including breast cancer, prostate cancer, colon cancer, gastric cancer, esophageal squamous cell carcinoma, and diffuse large B-cell lymphoma. The trials aim to improve cancer control, support survival after surgery or standard treatment, and explore whether newer therapies can add benefit over current care.

• Testing new approaches for early and advanced breast cancer
• Evaluating treatment strategies in prostate cancer and reducing treatment burden
• Studying perioperative and adjuvant options for gastric and colon cancers
• Exploring novel combinations for esophageal cancer and lymphoma

The oncology program at Medical Oncology includes studies that look for better disease control while aiming to preserve quality of life.

Clinical trials in digestive system diseases address cancers of the colon, stomach, and esophagus. The research is focused on improving outcomes after surgery or chemoradiation and identifying treatment strategies that may lower recurrence risk or extend survival.

• Assessing survival benefits in resected colon carcinoma
• Comparing preoperative treatment approaches for gastric adenocarcinoma
• Studying combined therapy options for esophageal cancer

These trials aim to refine standard cancer care in digestive tract malignancies and support more effective treatment planning.

Within female urogenital diseases and pregnancy-related research, the site is involved in studies of unexplained subfertility and infertility care. The main goal is to improve the chance of achieving a live birth and to better understand supportive treatment options used during fertility procedures.

• Evaluating ways to improve live birth rates in assisted reproduction
• Studying supportive care in intra-uterine insemination programs

This area reflects a patient-centered effort to make fertility treatment more effective and informative for couples seeking care.

Research in male urogenital diseases centers on prostate cancer, including both newly diagnosed and metastatic disease. The trials are looking at whether treatment can be made more efficient, less toxic, and better tailored to disease risk while maintaining cancer control.

• Studying treatment duration and restart strategies in low-volume metastatic prostate cancer
• Examining how prostate cancer therapy may affect other medications

These studies support more personalized prostate cancer management and may help reduce unnecessary treatment burden.

The site also conducts research in skin and connective tissue diseases, especially chronic spontaneous urticaria. The trials are focused on improving control of itching and hives in people who do not respond well to standard allergy treatment.

• Testing new options for symptom relief in chronic spontaneous urticaria
• Comparing active treatment with placebo to measure improvement in disease activity

These studies aim to offer better symptom management and a clearer path for patients with persistent allergic skin disease.

In nutritional and metabolic diseases, research at Deventer Ziekenhuis includes hypertriglyceridemia and broader metabolic risk linked to cardiovascular disease. The purpose of these trials is to see whether newer treatments can improve lipid levels and lower long-term cardiovascular risk.

• Lowering triglyceride levels in patients with severe lipid disorders
• Reducing cardiovascular risk in people with metabolic and atherosclerotic disease

This work connects metabolic care with prevention of heart and vascular complications.

Trials in metabolism and reproductive and urinary physiological phenomena support research across several disease areas, including heart disease, cancer, and fertility care. These studies are designed to better understand how treatments work in the body and how they may influence clinical outcomes.

• Examining treatment effects on drug handling and metabolism
• Supporting fertility-related research in assisted reproduction
• Investigating biological pathways linked to inflammation and cardiovascular risk

The broader research portfolio shows an interest in both practical treatment improvement and the biological processes behind disease.